Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to capitalize on the sector's growth.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity arrangements.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust project pipeline.

Co-GP / Platform:A family office could deploy into the Puget Sound life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a proven track record in securing leases and managing properties in high-demand areas like San Francisco.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline of high-quality lab spaces.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level to capitalize on the improving vacancy landscape.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator focused on converting vacant lab spaces to alternative uses, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to share in the promote.

Co-GP / Platform:A family office could deploy into the San Diego life science market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor or operator at the GP level, capitalizing on the current funding environment.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, focusing on life sciences properties that can benefit from strategic repositioning.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston-Cambridge life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of new developments.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor/operator at the GP level to capitalize on the increasing venture capital funding.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and gaining access to a pipeline of potential projects.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of opportunities amidst rising vacancy rates.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and aligning interests amid increased vacancy.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, particularly in light of the strong venture capital funding trends.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, focusing on life sciences developments in Raleigh-Durham.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to benefit from shared enterprise value.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a specialized operator at the GP level, sharing in the promote and accessing a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.